Trial intelligence / Profile preview

Esmolol in Sepsis Management

NCT06390748Phase 2Completed

Start
Jan 2021
Primary completion
Dec 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of esmolol in sepsis. Started Jan 2021; status: completed.

02

Drugs

esmolol
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT06390748.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06390748.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call